5 Jan 2018

Future of Metastatic Bladder Cancer Lies in Combination Immunotherapy, Expert Says

When combined with other agents, immunotherapy has been shown to provide an additional benefit for patients with bladder cancer, explains Arjun Balar, MD.

Read more...

• Danielle Bucco with Targeted Oncology

30 May 2017

FDA Approves Immunotherapy Drugs for Patients with Bladder Cancer

The Food and Drug Administration (FDA) in recent weeks has approved four immunotherapy drugs for bladder cancer, bringing the total number of approved immunotherapies for this disease to five. Known as checkpoint inhibitors, all four drugs work by “releasing the brakes” on the immune system and allowing immune cells to attack tumors.

Read more...

• Staff with National Cancer Institute